User profiles for John S. Schieffelin

John Schieffelin

Associate Professor of Pediatrics
Verified email at tulane.edu
Cited by 5170

[HTML][HTML] Clinical illness and outcomes in patients with Ebola in Sierra Leone

JS Schieffelin, JG Shaffer, A Goba… - New England journal …, 2014 - Mass Medical Soc
Background Limited clinical and laboratory data are available on patients with Ebola virus
disease (EVD). The Kenema Government Hospital in Sierra Leone, which had an existing …

Virus genomes reveal factors that spread and sustained the Ebola epidemic

…, M Sanchez-Lockhart, SF Schaffner, JS Schieffelin… - Nature, 2017 - nature.com
The 2013–2016 West African epidemic caused by the Ebola virus was of unprecedented
magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of …

[HTML][HTML] Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone

…, LE Hensley, JH Kuhn, C Nusbaum, JS Schieffelin… - Cell, 2015 - cell.com
The 2013–2015 Ebola virus disease (EVD) epidemic is caused by the Makona variant of
Ebola virus (EBOV). Early in the epidemic, genome sequencing provided insights into virus …

[HTML][HTML] Clinical sequencing uncovers origins and evolution of Lassa virus

…, M Rowland, M Heinrich, M Akdag, JS Schieffelin… - Cell, 2015 - cell.com
The 2013–2015 West African epidemic of Ebola virus disease (EVD) reminds us of how little
is known about biosafety level 4 viruses. Like Ebola virus, Lassa virus (LASV) can cause …

[HTML][HTML] Lassa fever in post-conflict Sierra Leone

JG Shaffer, DS Grant, JS Schieffelin… - PLoS neglected …, 2014 - journals.plos.org
Background Lassa fever (LF), an often-fatal hemorrhagic disease caused by Lassa virus (LASV),
is a major public health threat in West Africa. When the violent civil conflict in Sierra …

Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low …

…, F Nosten, A Papali, AJ Patterson, JS Schieffelin… - Jama, 2018 - jamanetwork.com
… Because sepsis itself cannot be identified with certainty, predictive validity instead evaluates
a potential criterion’s ability to identify, from among patients at risk for sepsis, those more …

[HTML][HTML] Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

…, PO Okokhere, OA Follarin, JS Schieffelin… - Nature …, 2016 - nature.com
Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The
epitopes of the Lassa virus (LASV) surface glycoproteins recognized by naturally infected …

New filovirus disease classification and nomenclature

…, B Ribner, PC Sabeti, JS Schieffelin… - Nature Reviews …, 2019 - nature.com
The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly
increased accumulation of human genotypic, phenotypic and clinical data, and improved our …

[HTML][HTML] Ebola virus disease and critical illness

…, I Crozier, E Ibrahima, MC Lamah, JS Schieffelin… - Critical Care, 2016 - Springer
As of 20 May 2016 there have been 28,646 cases and 11,323 deaths resulting from the
West African Ebola virus disease (EVD) outbreak reported to the World Health Organization. …

[HTML][HTML] Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of Lassa fever

…, M Leach, LM Moses, JS Schieffelin… - PLoS neglected …, 2015 - journals.plos.org
Background Zoonotic infections, which transmit from animals to humans, form the majority of
new human pathogens. Following zoonotic transmission, the pathogen may already have, …